share_log
Breakings ·  Sep 3 20:03
Cogent Biosciences Inc: Peak Interim Futility Analysis Completed With No Changes to Study
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment